Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.06.2018 | Review

Lithium use during pregnancy needs balanced decision making

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

In utero exposure to lithium during pregnancy does not appear to be associated with significantly increased risks for pregnancy/delivery outcomes, but caution is required.1
Fußnoten
1
The lithium-exposed group comprised pregnant women with lithium exposure during the index pregnancy. The mood-disorder reference group comprised pregnant women with a known history of mood disorder (i.e. bipolar disorder or major depressive disorder), without exposure to lithium from 90 days before pregnancy until delivery.
 
Literatur
1.
Zurück zum Zitat Munk-Olsen T, et al. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. The Lancet Psychiatry : [9 pages], 18 Jun 2018. Available from: URL: http://dx.doi.org/10.1016/S2215-0366(18)30180-9. Munk-Olsen T, et al. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. The Lancet Psychiatry : [9 pages], 18 Jun 2018. Available from: URL: http://​dx.​doi.​org/​10.​1016/​S2215-0366(18)30180-9.
2.
Zurück zum Zitat Galbally M, et al. Designing research that can untangle the effects in pregnancy of pharmacological treatments for mental disorders. The Lancet Psychiatry : [2 pages], 18 Jun 2018. Available from: URL: http://dx.doi.org/10.1016/S2215-0366(18)30214-1. Galbally M, et al. Designing research that can untangle the effects in pregnancy of pharmacological treatments for mental disorders. The Lancet Psychiatry : [2 pages], 18 Jun 2018. Available from: URL: http://​dx.​doi.​org/​10.​1016/​S2215-0366(18)30214-1.
Metadaten
Titel
Lithium use during pregnancy needs balanced decision making
Publikationsdatum
01.06.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-48103-3

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Ipilimumab

Case report

BCG vaccine

Case report

Phenytoin

Case report

Dasatinib

Case report

Imipramine